Marvell Technology
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Marvell Technology in real time with a live news feed covering Marvell Technology stock news, official press releases, company announcements, and an archive of historical Marvell Technology news. ...more
Loading news...
Loading more...
7:00 AM | Wednesday | May 20, 2026
Sign in to download news snippet
Calgary, Alberta--(Newsfile Corp. - May 20, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces the award of 50,001 deferred share units ("DSUs") to Marvel's three independent directors, in lieu of cash payment for directors' fees. The DSUs will all vest on May 19, 2027.
No data available for this time period.
Change the time range to see results.
Calgary, Alberta--(Newsfile Corp. - May 20, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces the award of 50,001 deferred share units ("DSUs") to Marvel's three independent directors, in lieu of cash payment for directors' fees. The DSUs will all vest on May 19, 2027.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Marvell Technology, Inc. (NASDAQ: MRVL), today announced a quarterly dividend of $0.06 per share of common stock payable on April 30, 2026 to stockholders of record as of April 10, 2026. About Marvell To deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers.
Trusted by the world's leading technology companies for over 30 years, we move, store, process.
Calgary, Alberta--(Newsfile Corp. - March 18, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company"), a drug discovery company developing novel therapeutics for autism spectrum disorder and related conditions, is pleased to announce that the US Patent Office has issued Patent No. 12,570,656 B2 for MB-204 granting broad composition of matter and methods of use claims titled "Purine Compounds for Treating Disorders.
LOS ANGELES--(BUSINESS WIRE)---- $MRVL #AI--OFC 2026 – Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced Marvell® Structera™ S 30260―a new 260-lane CXL switch device that enables rack-level memory pooling. Working in concert with Marvell Structera A near-memory accelerators, Structera X memory-expansion controllers and Alaska® P PCIe/CXL retimers, the new switch allows data center operators to further increase memory bandwidth and capacity by pr.
Read full article
LOS ANGELES--(BUSINESS WIRE)---- $MRVL #AI--OFC 2026 – Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced Marvell® Structera™ S 60260, the industry's first 260-lane PCIe 6.0 switch. Leveraging industry-leading interconnect solutions through the recent acquisition of XConn Technologies, the new industry's highest-radix PCIe switch extends the Marvell end-to-end PCIe portfolio, offering unique levels of scale-up AI data center performance and desig.
Read full article
LOS ANGELES--(BUSINESS WIRE)---- $MRVL #AI--OFC 2026 – Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions and Lumentum Holdings Inc. (NASDAQ: LITE), a market-leading designer and manufacturer of optical and photonic products, today announced a live demonstration of Marvell® optical connectivity solutions interoperating with Lumentum's optical circuit switching (OCS) platform. The integrated, rack-level system will be showcased in the Marvell booth (#1600) at OFC.
Read full article
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $MRVL #AI--Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced it will showcase the industry's most comprehensive portfolio of AI data center connectivity solutions at OFC 2026—March 15 to 19 at the Los Angeles Convention Center in Los Angeles, California. As AI infrastructure scales exponentially, connectivity has become the primary bottleneck of modern hyperscale and cloud data centers, and new, dedicated.
Read full article
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $MRVL #AI--Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced a major expansion of its 1.6T optical DSP platform portfolio, advancing the industry's transition from 800G into 1.6T next-generation AI data center connectivity.
Marvell has a multi-generational history of industry firsts. The company was the first to introduce 200G/lane 1.6T DSPs in 5nm with Marvell® Nova in 2023, followed by the 3nm 1.6T Ara.
No data available for this time period.
Change the time range to see results.